BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 29366841)

  • 1. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Guthrie EA; Hamlin PJ; Ford AC
    Gastroenterology; 2018 May; 154(6):1635-1646.e3. PubMed ID: 29366841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors.
    Goodhand JR; Wahed M; Mawdsley JE; Farmer AD; Aziz Q; Rampton DS
    Inflamm Bowel Dis; 2012 Dec; 18(12):2301-9. PubMed ID: 22359369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease.
    Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
    Am J Gastroenterol; 2016 Apr; 111(4):541-51. PubMed ID: 27002800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.
    Subramanian S; Asher R; Weston W; Rimmer M; McConville A; Malin A; Jackson R; Collins P; Probert C; Dibb M; Rhodes JM
    Inflamm Bowel Dis; 2016 Aug; 22(8):1902-7. PubMed ID: 27243590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease.
    Targownik LE; Sexton KA; Bernstein MT; Beatie B; Sargent M; Walker JR; Graff LA
    Am J Gastroenterol; 2015 Jul; 110(7):1001-12; quiz 1013. PubMed ID: 26077178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is moderate red wine consumption safe in inactive inflammatory bowel disease?
    Swanson GR; Tieu V; Shaikh M; Forsyth C; Keshavarzian A
    Digestion; 2011; 84(3):238-44. PubMed ID: 21876358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
    Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
    Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional treatment regimens for ulcerative colitis alleviate fatigue - an observational cohort study.
    Grimstad T; Norheim KB; Kvaløy JT; Isaksen K; Leitao K; Carlsen A; Karlsen LN; Aabakken L; Omdal R
    Scand J Gastroenterol; 2016 Oct; 51(10):1213-9. PubMed ID: 27310658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    García-Sánchez V; Iglesias-Flores E; González R; Gisbert JP; Gallardo-Valverde JM; González-Galilea A; Naranjo-Rodríguez A; de Dios-Vega JF; Muntané J; Gómez-Camacho F
    J Crohns Colitis; 2010 Jun; 4(2):144-52. PubMed ID: 21122498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between inflammatory bowel disease and subsequent depression or anxiety disorders - A retrospective cohort study of 31,728 outpatients.
    Roderburg C; Yaqubi K; Konrad M; May P; Luedde T; Kostev K; Loosen SH
    J Psychiatr Res; 2024 Jan; 169():231-237. PubMed ID: 38048672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.
    Mittermaier C; Dejaco C; Waldhoer T; Oefferlbauer-Ernst A; Miehsler W; Beier M; Tillinger W; Gangl A; Moser G
    Psychosom Med; 2004; 66(1):79-84. PubMed ID: 14747641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study.
    Huppertz-Hauss G; Lie Høivik M; Jelsness-Jørgensen LP; Henriksen M; Høie O; Jahnsen J; Hoff G; Moum B; Bernklev T
    Inflamm Bowel Dis; 2016 Jul; 22(7):1679-87. PubMed ID: 27206016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease.
    Horst S; Chao A; Rosen M; Nohl A; Duley C; Wagnon JH; Beaulieu DB; Taylor W; Gaines L; Schwartz DA
    Dig Dis Sci; 2015 Feb; 60(2):465-70. PubMed ID: 25274158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions.
    van der Have M; Fidder HH; Leenders M; Kaptein AA; van der Valk ME; van Bodegraven AA; Dijkstra G; de Jong DJ; Pierik M; Ponsioen CY; van der Meulen-de Jong AE; van der Woude CJ; van de Meeberg PC; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; Bolwerk CJ; Vermeijden JR; Siersema PD; Oldenburg B; ;
    Inflamm Bowel Dis; 2015 Feb; 21(2):369-77. PubMed ID: 25569738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.
    Chung-Faye G; Hayee B; Maestranzi S; Donaldson N; Forgacs I; Sherwood R
    Inflamm Bowel Dis; 2007 Nov; 13(11):1374-8. PubMed ID: 17577247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease.
    Guthrie E; Jackson J; Shaffer J; Thompson D; Tomenson B; Creed F
    Am J Gastroenterol; 2002 Aug; 97(8):1994-9. PubMed ID: 12190166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.